Principal Financial Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-246,429
| Closed | -$4.75M | – | 2310 |
|
|
2025
Q1 | $4.75M | Buy |
246,429
+41,279
| +20% | +$796K | ﹤0.01% | 1587 |
|
|
2024
Q4 | $3.66M | Buy |
205,150
+147,003
| +253% | +$2.62M | ﹤0.01% | 1676 |
|
|
2024
Q3 | $1.27M | Buy |
58,147
+22,014
| +61% | +$482K | ﹤0.01% | 1826 |
|
|
2024
Q2 | $282K | Buy |
36,133
+20,553
| +132% | +$160K | ﹤0.01% | 2067 |
|
|
2024
Q1 | $64.5K | Buy |
15,580
+2,202
| +16% | +$9.12K | ﹤0.01% | 2321 |
|
|
2023
Q4 | $34.9K | Buy |
13,378
+1,294
| +11% | +$3.38K | ﹤0.01% | 2354 |
|
|
2023
Q3 | $22.6K | Sell |
12,084
-1,595
| -12% | -$2.98K | ﹤0.01% | 2408 |
|
|
2023
Q2 | $34.3K | Buy |
+13,679
| New | +$34.3K | ﹤0.01% | 2384 |
|